Answers are grounded in this paper and cite their sources.
Senior specialists will remember the IVY method, or bleeding time test, a method used in the early 20th century to evaluate primary hemostasis. At present, this method sleeps in old books, as ancient and antique as dinosaurs. Nowadays, dried blood spot (DBS) analysis is a widely known method used in clinical laboratories worldwide, mainly in neonatal screening and in pharmacokynetic, toxicological and infectious disease studies. By this method, some drops of blood (some microliters) are drawn from the heel or finger via a relatively painless puncture and placed onto a designated filter paper. With this simple method, the blood sample is easily shipped to the laboratory, which makes this technique very adequate for neonatal screening. The World Health Organization recommends the use of DBS for screening for infectious diseases such as hepatitis B, C, and human immunodeficiency virus (HIV) in countries with deficient healthcare services [1]. However, although the majority of blood samples – virtually all liquid – are analyzed in the central laboratory, the use of DBS is anecdotal. The chief executive officer (CEO) of Theranos, a promising blood testing start-up, was recently convicted of fraud for duping investors about the effectiveness of a technology her company had supposedly developed, which could detect multiple diseases from a few drops of capillary blood [2]. The history of this company, which was initially considered a unicorn in Silicon Valley, and her protagonist, an entepreneur that used to be compared with Steve Jobs, had all the ingredients of a thriller. This history teaches investors and laboratories that promises not based on scientific evidence should be approached with caution. However, Theranos technology pointed to one of the most compelling needs in healthcare: developing a blood sampling method that requires a minimal volume of blood and can be used out of the hospital. Capillary blood sampling is a relatively painless procedure whereby a small volume of blood can be drawn by the patient. Various companies from different countries, including Spain, offer home-collect biochemistry kits for the analysis of capillary blood that include blood collection and shipping material. At-home blood collection would be extremely useful for patients living in remote areas far from blood collection centers, and could also complement the work of clinicians through the use of telemedicine. As a result of the pandemic, an increasing number of patients are reluctant to visit hospitals. These centers are frequently saturated, and remote blood sampling would alleviate the workload of laboratory collection centers. The use of small amounts of blood would clearly benefit some groups of patients, including pediatric, elderly, and chronic and cancer patients, who need frequent blood tests. Some patients are afraid of blood draws, and would show better tolerance to a less aggressive technique. However, this technique may not be recommended for some types of patients, including patients with circulatory problems, inflammation in the puncture site or coagulation problems. Laboratorymedicine specialists should approach these needs with an evidence-based rigorous approach. The preanalytical phase is critical and, although simple, needs to be adequately completed to ensure that the analytical process is robust, with acceptable variability. Methodological guides, such as CLSI GP42-ED7 of 2020 [3], should be adapted for inexperienced operators to be able to complete the process. There is a variety of self-sampling kits available in the market that allow to draw small amounts of capillary blood using lancets or more sophisticated devices such as those developed by Yourbio Health or Tasso. These systems are designed to provide an adequate sample of blood and avoid heterogeneity, especially as a result of contamination with interstitial or intracellular fluid during finger “milking”. Inadequate handling may also cause hemolysis. There are tubes with a maximum volume of 1 mL for the collection of capillary blood, similar to *Corresponding author: Álvaro González, PhD, Departamento de Bioquímica, Clínica Universidad de Navarra, Avenida Pío XII 36, 31008 Pamplona, Spain; and Navarra Institute for Health Research (IdiSNA), Pamplona, Spain, Phone: +34 948 255400, Fax: +34 948 296 500, E-mail: agonzaleh@unav.
No takes yet. Share an insight, caveat, or question.
González et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: